Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1366264rdf:typepubmed:Citationlld:pubmed
pubmed-article:1366264lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C0680022lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C0026160lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C0005823lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C0232105lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:1366264lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:1366264pubmed:issue2lld:pubmed
pubmed-article:1366264pubmed:dateCreated1995-6-9lld:pubmed
pubmed-article:1366264pubmed:abstractTextCurrently normotensive offspring of essential hypertensive parents often have disturbances in blood pressure (BP) regulation such as abnormalities in electrolyte homoeostasis, increased salt-sensitivity and/or impaired renal Na(+)-excretion. Whether an altered reactivity to mineralocorticoids may also play a role is presently unknown. Therefore, we investigated BP (recorded during 24 h), plasma atrial natriuretic factor (ANF), cyclic guanosine monophosphate (cGMP), aldosterone (PA) and renin activity (PRA), 24-h urine electrolyte and cGMP excretions measured on 4 consecutive days, as well as other variables, after 1 week on placebo and after 3 weeks of 9 alpha-fludrocortisone-acetate (9 alpha F) administration, 0.6 mg/d in 12 normotensive sons of essential hypertensive parents (SEH) and 12 body-mass-index- and age-matched (25 +/- 1[+/-SEM]yr) sons of normotensive parents (SN). On placebo, the 2 groups did not differ significantly in average 24 h BP (mean BP 95 +/- 2 vs 95 +/- 2 mmHg), plasma-ANF (40 +/- 7 vs 30 +5 pg/ml), cGMP (6 +/- 0.4 vs 6 +/- 0.5 nmol/l), PRA (1.3 +/- 0.1 vs 1.6 +/- 0.2 ng/ml/h), PA (9 +/- 0.5 vs 10 +/- 0.9 ng/dl), hematocrit (44 +/- 0.7 vs 44 +/- 0.4%) and 96-h urinary-Na+ (mean 205 +/- 13 vs 195 +/- 16 mmol/d), -K+ (69 +/- 6 vs 78 +/- 7 mmol/d) or -cGMP (461 +/- 35 vs 483 +/- 32 nmol/d). 9 alpha F significantly increased BP in SEH (p < 0.005) but not SN (107 +/- 2 vs 100 +/- 2 mmHg, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1366264pubmed:languageenglld:pubmed
pubmed-article:1366264pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1366264pubmed:citationSubsetIMlld:pubmed
pubmed-article:1366264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1366264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1366264pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1366264pubmed:statusMEDLINElld:pubmed
pubmed-article:1366264pubmed:monthAuglld:pubmed
pubmed-article:1366264pubmed:issn0803-7051lld:pubmed
pubmed-article:1366264pubmed:authorpubmed-author:WeidmannPPlld:pubmed
pubmed-article:1366264pubmed:authorpubmed-author:FerrariPPlld:pubmed
pubmed-article:1366264pubmed:authorpubmed-author:ShawSSlld:pubmed
pubmed-article:1366264pubmed:authorpubmed-author:AllemannYYlld:pubmed
pubmed-article:1366264pubmed:authorpubmed-author:TravagliniMMlld:pubmed
pubmed-article:1366264pubmed:authorpubmed-author:SchildCClld:pubmed
pubmed-article:1366264pubmed:issnTypePrintlld:pubmed
pubmed-article:1366264pubmed:volume1lld:pubmed
pubmed-article:1366264pubmed:ownerNLMlld:pubmed
pubmed-article:1366264pubmed:authorsCompleteYlld:pubmed
pubmed-article:1366264pubmed:pagination86-91lld:pubmed
pubmed-article:1366264pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:meshHeadingpubmed-meshheading:1366264-...lld:pubmed
pubmed-article:1366264pubmed:year1992lld:pubmed
pubmed-article:1366264pubmed:articleTitleEnhanced blood pressure response to mineralocorticoid stimulation in normotensive members of hypertensive families.lld:pubmed
pubmed-article:1366264pubmed:affiliationMedizinische Poliklinik, University of Berne, Switzerland.lld:pubmed
pubmed-article:1366264pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1366264pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1366264pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed